RHUMBLINE ADVISERS - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 173 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$1,571,000
-46.8%
77,944
-1.4%
0.00%
-50.0%
Q2 2021$2,951,000
+38.7%
79,063
-5.0%
0.00%
+33.3%
Q1 2021$2,128,000
+8.7%
83,217
-6.3%
0.00%0.0%
Q4 2020$1,957,000
+21.0%
88,831
-1.2%
0.00%0.0%
Q3 2020$1,618,000
-38.0%
89,934
-12.4%
0.00%
-25.0%
Q2 2020$2,609,000
+83.3%
102,697
+32.6%
0.00%
+33.3%
Q1 2020$1,423,000
-13.7%
77,443
+3.5%
0.00%0.0%
Q4 2019$1,648,000
+57.9%
74,804
+2.9%
0.00%
+50.0%
Q3 2019$1,044,000
-8.2%
72,690
+0.7%
0.00%0.0%
Q2 2019$1,137,000
+10.7%
72,163
+3.0%
0.00%0.0%
Q1 2019$1,027,000
+43.0%
70,078
+4.3%
0.00%0.0%
Q4 2018$718,000
+15.6%
67,192
+65.1%
0.00%
+100.0%
Q3 2018$621,000
+19.0%
40,709
-4.4%
0.00%0.0%
Q2 2018$522,000
+569.2%
42,601
+194.6%
0.00%
Q1 2016$78,000
-54.7%
14,4630.0%0.00%
-100.0%
Q4 2015$172,000
+59.3%
14,463
+10.3%
0.00%
Q3 2015$108,000
-38.3%
13,108
+4.7%
0.00%
-100.0%
Q2 2015$175,00012,5150.00%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,355,392$29,859,0006.21%
Bain Capital Life Sciences Investors, LLC 3,080,237$67,858,0004.26%
DAFNA Capital Management LLC 587,756$12,948,0003.85%
SILVERARC CAPITAL MANAGEMENT, LLC 227,388$5,009,0002.91%
RTW INVESTMENTS, LP 7,253,857$159,802,0002.68%
Parkman Healthcare Partners LLC 331,513$7,303,0001.87%
Evolutionary Tree Capital Management, LLC 60,864$1,341,0001.02%
Eagle Health Investments LP 69,000$1,520,0000.97%
Woodline Partners LP 1,358,796$29,934,0000.79%
Affinity Asset Advisors, LLC 40,000$881,0000.47%
View complete list of DICERNA PHARMACEUTICALS INC shareholders